Hangzhou Zenshine Pharmaceuticals Co., Ltd.

For profitWebsite ↗

Also known as: Hangzhou Zenshine Pharmaceuticals Co., Ltd. | Nanjing Zenshine Pharmaceuticals | Zenshine Pharmaceutical, Inc. | Zenshine Pharmaceuticals

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 18, 2020

Last known activity

Dec 20, 2025

Timeline

2010s

Jun 1, 2018
Hangzhou Zenshine Pharmaceuticals Co., Ltd.— Founded

Drugs by trial phase (5 distinct, 16 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

zx-101a

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (20)

NCT07310134Lead sponsorPhase 1Dec 20, 2025
NCT07095257Lead sponsorPhase 3Oct 13, 2025
NCT06841926Lead sponsorPhase 1Feb 20, 2025
NCT06669351Lead sponsorPhase 3Nov 30, 2024
NCT06099873Lead sponsorPhase 3Oct 25, 2023
NCT06057103Lead sponsorPhase 1Aug 25, 2023
NCT05955027Lead sponsorPhase 1Aug 15, 2023
NCT05949385Lead sponsorPhase 1Jul 12, 2023
NCT05720091Lead sponsorPhase 1Feb 13, 2023
NCT05711797Lead sponsorPhase 1Nov 2, 2022
NCT05702489Lead sponsorPhase 2/Phase 3Sep 17, 2022
NCT05258266Lead sponsorPhase 1/Phase 2Mar 9, 2022
NCT05258266Study directorPhase 1/Phase 2Mar 9, 2022
NCT05269940Lead sponsorPhase 1/Phase 2Jan 27, 2022
NCT05269940Study directorPhase 1/Phase 2Jan 27, 2022

Details

Founded: Hangzhou, CN Jun 1, 2018
Last known activity: Dec 20, 2025